The localization of components of coagulation system in breast cancer in loco;Ocena ekspresji in loco czynników układu krzepniecia krwi w raku piersi

Onkologia Polska

Volumn 9, Issue 3, 2006, Pages 69-74

  Sierko, Ewa ^a   Sawicki, Zbigniew ^a   Hempel, Dominika ^a   Sulkowski, Stanisław ^b   Zimnoch, Lech ^b   Wojtukiewicz, Marek Z ^a  

^a Zaklad Onkologii AM   (Poland)

^b AM   (Poland)

Author keywords

Blood coagulation; Breast cancer

Indexed keywords

BLOOD CLOTTING FACTOR; FIBRIN; FIBRINOGEN; PROTHROMBIN; THROMBOPLASTIN;

ARTICLE; BLOOD CLOTTING; BREAST CANCER; CANCER CELL; CONNECTIVE TISSUE; DISEASE SEVERITY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; MACROPHAGE; PROTEIN EXPRESSION; STROMA; TUMOR GROWTH;

EID: 33845919792     PISSN: 15056732     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Lee A.Y., Levine M.N.: Venous thromboembolism and cancer: risks and outcomes. Circulation 2003, 107, 117-121.
2. Wojtukiewicz M.Z., Sierko E.: Zaburzenia hemostazy u chorych na nowotwory. [w:] Onkologia kliniczna, Krzakowski M. (red.). Wyd. I, Wydawnictwo Medyczne Borgis, Warszawa 2001, 379-406.
3. Caine G.J., Stonelake P., Rea D. i wsp.: Coagulopathic complications in breast cancer. Cancer 2003, 98, 1578-1586.
4. Pritchard K.I., Paterson A.H., Paul N.A. i wsp.: Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. J. Clin. Oncol. 1996, 14, 2731-2737.
5. Clashen P.C., van de Velde C.J., Julien J.P. i wsp.: Thromboembolic complication after perioperative chemotherapy in women with early breast cancer. J. Clin. Oncol. 1994, 12, 1266-1271.
6. Ozyilkan O., Baltali E., Ozdemir O. i wsp.: Haemostatic changes; plasma levels of alpha2-antiplasmin-plasmin complex and thrombin-antithrombin III complex in female breast cancer. Tumori 1998, 84, 364-367.
7. Wojtukiewicz M.Z., Rucińska M., Kłoczko J. i wsp.: Profiles of plasma serpins in patiens with advanced malignant melanoma, gastric cancer and breast cancer. Haemostasis 1998, 28, 7-13.
8. Wojtukiewicz MZ, Zacharski L.R., Memoli V.A. i wsp.: Abnormal regulation of coagulation/fibrinolysis in small cell carcinoma of the lung. Cancer 1990, 65, 481-485.
9. Wojtukiewicz M.Z., Sierko E., Rak J.: Contribution of the hemostatic system to angiogenesis in cancer. Semin. Thromb. Hemost. 2004, 30, 5-20.
10. Wojtukiewicz M.Z., Rucińska M., Zimnoch L. i wsp.: Expression of prothrombin fragment 1+2 in cancer tissue as an indicator of local activation of blood cogulation. Thromb. Res. 2000, 97, 335-342.
11. Wojtukiewicz MZ, Rucińska M., Zacharski L.R. i wsp.: Localization of blood coagulation factors in situ in pancreatic carcinoma. Thromb. Haemost. 2001, 86, 1416-1420.
12. Wojtukiewicz M.Z., Zacharski L.R., Memoli V.A. i wsp.: Malignant melanoma. Interaction with coagulation and fibrinolysis pathways in situ. Am. J. Clin. Pathol. 1990, 93, 516-521.
13. Vrana J.A., Stang M.T., Grande J.P. i wsp.: Expression of tissue factor in tumor stroma correlates with progression to invasive human breast cancer: paracrine regulation by carcinoma cell-derived members of the transforming growth factor beta family. Cancer Res. 1996, 56, 5063-5070.
14. Bromberg M.E., Konigsberg W.H., Madison J.F. i wsp.: Tissue factor promotes metastasis by a pathway independent of blood coagulation. Proc. Natl. Acad. Sci. USA 1995, 92, 8205-8209.
15. Jiang X., Bailly M.A., Paneti T.S. i wsp.: Formation of tissue factor-factor VIIa-factor Xa complex promotes cellular signaling and migration of human breast cancer cells. J. Thromb. Haemost. 2004, 2, 93-101.
16. Wojtukiewicz M.Z., Sierko E., Zacharski L.R. i wsp.: Tissue factor-dependent coagulation activation and impaired fibrinolysis in situ in gastric cancer. Semin. Thromb. Hemost. 2003, 29, 291-299.
17. Seto S., Onodera H., Kaido T. i wsp.: Tissue factor expression in human colorectal carcinoma: correlation with hepatic metastasis and impact on prognosis. Cancer 2000, 88, 295-301.
18. Ueno T., Toi M., Koike M. i wsp.: Tissue factor expression in breast cancer tissues: its corelation with prognosis and plasma concentration. Br. J. Cancer 2000, 83, 164-170.
19. Lwaleed B.A., Chrisholm M., Francis I.L. i wsp.: The significance of measuring monocyte tissue factor activity in patients with breast and colorectal cancer. Br. J. Cancer 1999, 80, 279-285.
20. Lwaleed B.A., Bass P.S., Francis I.L. i wsp.: Urinary tissue factor: a potent marker of disease. J. Pathol. 1999, 188, 3-8.
21. Costantini V., Zacharski L.R., Memoli V.A. i wsp.: Fibrinogen deposition without thrombin generation in primary human breast cancer tissue. Cancer Res. 1991, 51, 349-353.
22. Falanga A., Rickles F.R.: Patophysiology of the thrombophilic state in the cancer patient Semin. Thromb. Hemost. 1999, 25, 173-182.
23. Wojtukiewicz M.Z., Tang T.G., Ben-Josef E. i wsp.: Solid tumor express functional "tethered ligand" thrombin receptor. Cancer Res. 1995, 55, 698-704.
24. Wojtukiewicz M.Z., Sierko E., Zacharski L.R.: Interfering with hemostatic system components: possible new approaches to antiangiogenic therapy. Semin. Thromb. Hemost. 2004, 30, 146-156.
25. Wojtukiewicz M.Z., Kozłowski L., Ostrowska K. i wsp.: Low-molecular-weight heparin treatment for malignant melanoma: a pit clinical trial. Thromb. Haemost. 2003, 89, 405-407.